{"name":"Afexa Life Sciences Inc","slug":"afexa-life-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9UTVdnRmpLbm42dTdYRGJXem9jdDExMk56eTdhWHJXd1c0SS1VenJPM3RSZ1NqOWhudko2dWVUV0pjZmlBNzViMUpWNUFDY1VsSmFMR1p3bFk2emktN0Z6UTZTM3ZyWm5EYURKbjdzRTFWUmJ5akw4eE5Nbw?oc=5","date":"2016-04-11","type":"pipeline","source":"CBC","summary":"Potential class action lawsuit says Cold-fX doesn't work and dupes consumers - CBC","headline":"Potential class action lawsuit says Cold-fX doesn't work and dupes consumers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE4yM0dXYWtIc1FuZEpqYWRvQUJKYlJocUxaRGQxMVk3cEh0ckFTaXF2MzdzdEZUWHdKUjJVWGxldWdnUFV1LW0zeXBvYldvNndf?oc=5","date":"2016-02-01","type":"trial","source":"Fortune","summary":"Study Says This Cold Medicine Doesn’t Actually Fight Colds - Fortune","headline":"Study Says This Cold Medicine Doesn’t Actually Fight Colds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9qYkQ5QllsaHF2Q01IYjBOTG12a1kwc0ZVWGtVWWxxNFZJamx3X0J4ZE5XZm5vNmE2N0dyN01QYy1WcFJIcGVHc0ozdmFqQjZlOG50X2l6SmNTV0hHS3MxVi1UU0RGcUtMS3BlRjB3N2JYMVA5M2dobg?oc=5","date":"2015-10-24","type":"pipeline","source":"Business Insider","summary":"The rise and fall of Valeant - Business Insider","headline":"The rise and fall of Valeant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNRmNSOGdSOHd1UHhnUzFvV240QjhNa0RHUlFEanppTkVkUFE2aWFuWEMzUlQwbVh0WEphR3FxNkE2Qk1rczhINzBsa1VVQ3JLYXhscWxkNHhGQnFESXNTYm1xd3RDTE9RMDFFdG9oZ0ZwRkZCSTdZdERrcHJLcmdVX1gwRWFIX1ljZVhNWDVuMzVkMURBS1BGS2dLSDQxZWs3OE9UajJmZXhGejFvVXJuM0xLTGh6QWxuWmMyR3F3Y0tUdXpEUUZhbXN2aWdJdw?oc=5","date":"2014-04-18","type":"pipeline","source":"The Globe and Mail","summary":"After brain injury, tenacious CEO builds new drug company - The Globe and Mail","headline":"After brain injury, tenacious CEO builds new drug company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOcy1ZZkFCbXF2VktCbjRkUlkxM09iOUp2QmxHV01naVMxZW5STU45WkV6SjB5UWpZLXRJdmxuRXE2akJ0aV9qSmhqZ1ZXcmpLbTYxNTB6bE5hM3ROMTZqN1BpOThxYWlYMVFidVdnX3ZVVFZrX1drUW1xanhTSjlRX3V6bVpfUTlvRzV5RjZwWmNKOWp4TjhRTlN2VGRWVElaU0ZBWmdSSVBBY3FDdktfOGxOaFRaQTdIS3RpMFVjUXdTemU4QXZPVHNIdkd5d1hzQWNLalpWalhmYjBuMVo5dU5B?oc=5","date":"2013-10-11","type":"pipeline","source":"The Globe and Mail","summary":"Mind behind Cold-Fx launches product line for aging boomers - The Globe and Mail","headline":"Mind behind Cold-Fx launches product line for aging boomers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPdlE5T3U2eVZGbE1oZUhpX2h5djJUdC1CZFFVazJuQkxGdEh1eXhyQmJuTmF6eEgtWTFNTjNzUmdKUXVaTFZyYUJHUW1KV0FhemY2UHdJUTB5d3NRSmF1bThvU2g0VUdxYVZmblEtVjI3QU9BWGVvMVNneEtTLWpSRUNnYThpUjVBSUc4eTVMVDNoSmZ2RG1xdGxURVpCbjVZZFREbEhDQmxqaUlPdXNaZXJfck5FSl9VWkttcHFaZWhXbmNW?oc=5","date":"2012-04-03","type":"pipeline","source":"The Globe and Mail","summary":"Drug giant Valeant moving global head office to Montreal region - The Globe and Mail","headline":"Drug giant Valeant moving global head office to Montreal region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOeGZJaW95OU1ZRGZ0alVTRnFlU1VwQlhVeHlOT3ljT2Q1dnNRMk1xcG5WZVhLbTBnMXdjMnhkVGt2MWZ2ZkxwX2I0U1BuSXByOG5QdFdyNzhoT1NjNjgySkxJYlFraXE0dDVQSmRlTWh2NTBrbnNTdmVZeVNubS1tWkp6LXZSUE9qcUlBc0gtUF9Qckg3UHRtaDE4T0VOUjZqN3lVWFRpX19obUdVemxPS2laYTNYZFkxeFRSa2tGLVhPM09QMnl1M2JncXBMWXQ1U3VCMzc0Yw?oc=5","date":"2011-10-03","type":"deal","source":"proactiveinvestors.com","summary":"Paladin Labs pulls bid for Afexa Life Sciences, paves way for Valeant deal - proactiveinvestors.com","headline":"Paladin Labs pulls bid for Afexa Life Sciences, paves way for Valeant deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQQUxqSGdYZFlXbk1uRjlqZndpSmN0V1Yyc3dDd2NwcTVfd3MxWWYzallXdVl6elRCQ3BueVUxcjFnX1FUaldMaV8zb1VtWC1TSTdUclVmSlYxUldVWFNaYXdKUUxZUGgxMU1SZmVKVThBMTh4QVdWdzV4RkxFbjY5eXNpc2gwdFNPeXQ5bmhWZEo4dmJzVDJ4MHhBU0hjakRQVmVfVVhNZUI4dnJ0LWxJ?oc=5","date":"2011-10-03","type":"pipeline","source":"Global News","summary":"Paladin drops bid for Cold-FX maker Afexa, cashes in as minority shareholder - Global News","headline":"Paladin drops bid for Cold-FX maker Afexa, cashes in as minority shareholder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNdkpROWdoZklpV295d0NwTUc0RC0tbUdwTU1xU2JvdW5CaURnRnRnVkFYOS1ONW9jdDhUZi1kYVRhNEpKakRpR3pJMjFZVEdHRUd2b185WUxXa3lvREZZWkthM194Nlhac1VDNTRaTXk4RGpsU3hFN24tQjVLMXEtcHI4RDJxOU1DbzdhZWV0ODJKMGhfallGN2M0Rlpoc2N6?oc=5","date":"2011-09-15","type":"pipeline","source":"The Globe and Mail","summary":"Paladin extends hostile bid for Afexa - The Globe and Mail","headline":"Paladin extends hostile bid for Afexa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPN21IOGlOUHQ4c08tSl9SWU5zMFdOcHIxdkhMQTh2cWhpWUdLY25Uek1Ga1dCTkUycHBvaHBZMFBhWmVqa2xoTy16VEZsRFF1a2h6MXBqQlpWQVpUZ0s0MUg5VHN4LUUyRlFzckZ2c0VyVEYyREw5WkxTV0dGZ25sa29DbHo4UQ?oc=5","date":"2011-08-30","type":"pipeline","source":"CBC","summary":"Valeant bids for Cold-FX maker Afexa - CBC","headline":"Valeant bids for Cold-FX maker Afexa","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}